How should I manage a patient whose urinalysis shows hematuria, red blood cells, white blood cells, bacteria, hyaline casts, budding yeast, and calcium oxalate crystals?

Management of Urinalysis Showing Hematuria with Multiple Abnormalities

This patient requires urgent evaluation for both urologic malignancy and concurrent urinary tract infection, with immediate treatment of the UTI followed by risk-stratified hematuria workup after confirming infection resolution at 12 weeks. 1, 2

Immediate Actions

1. Treat the Urinary Tract Infection

• The presence of WBCs, bacteria, and budding yeast indicates concurrent UTI and possible fungal infection
• Obtain urine culture before initiating antibiotics
• Treat with appropriate antimicrobials based on culture results
• Critical caveat: Do NOT assume the hematuria is solely due to infection—UTI and malignancy frequently coexist 1

2. Confirm True Hematuria

• Verify this is a properly collected, non-contaminated specimen
• The presence of calcium oxalate crystals and amorphous material may indicate specimen issues
• Repeat urinalysis after UTI treatment to confirm persistent hematuria

Risk Stratification (After UTI Resolution)

Using the 2025 AUA/SUFU criteria, determine the patient's risk category based on 1:

Low/Negligible Risk (0-0.4% malignancy) - ALL must be met:

• 3-10 RBC/HPF
• Women <60 years OR Men <40 years
• Never smoker or <10 pack-years
• No additional urothelial cancer risk factors

Intermediate Risk (0.2-3.1% malignancy) - ONE OR MORE:

• 11-25 RBC/HPF
• Women ≥60 years OR Men 40-59 years
• 10-30 pack-year smoking history
• Any additional risk factors (occupational exposures, chronic UTI, pelvic radiation, analgesic abuse)

High Risk (1.3-6.3% malignancy) - ONE OR MORE:

• 25 RBC/HPF

• Men ≥60 years

• 30 pack-year smoking history

• Multiple risk factors present

Timing of Confirmatory Testing

Recheck urinalysis at 12 weeks post-antibiotic treatment, not earlier 2. This timeline is critical because:

• Only 38% of UTI-related hematuria resolves by 30 days
• 50% resolves by 60 days (median)
• 75% resolves by 180 days
• Retesting before 12 weeks leads to false-positive persistent hematuria and unnecessary workup
• After 12 weeks, <21% will have persistent positive results if truly UTI-related

Definitive Workup (If Hematuria Persists After 12 Weeks)

Concurrent Nephrology Evaluation Needed If:

• Hyaline casts present (as in this case—suggests possible glomerular involvement)
• Proteinuria on dipstick
• Elevated serum creatinine
• Hypertension
• Dysmorphic RBCs on phase-contrast microscopy 3, 4

Do NOT delay urologic evaluation while awaiting nephrology assessment—both evaluations should proceed simultaneously 3

Urologic Evaluation Components:

Upper Tract Imaging:

• Multiphasic CT urography is the gold standard 3, 4
• Sensitivity 92%, specificity 93% for detecting pathology 5
• Identifies hydronephrosis, calculi, renal masses, and ureteral lesions
• Alternative: Renal ultrasound only if age ≤40 years with low-risk features 5

Lower Tract Evaluation:

• Cystoscopy is mandatory for all risk categories with persistent hematuria 1
• Most hematuria-related cancers are bladder cancers, optimally detected by cystoscopy
• Delays in bladder cancer diagnosis increase cancer-specific mortality by 34% and all-cause mortality by 15% 1
• Imaging alone is insufficient—underuse of cystoscopy is a major diagnostic pitfall 1

Urine Cytology:

• NOT recommended for routine asymptomatic hematuria evaluation 4, 6
• Insufficient sensitivity to obviate further workup if negative
• Only consider if high-risk features present (irritative symptoms, occupational exposures)

Special Considerations for This Case

The hyaline casts are particularly important—while they can occur with concentrated urine or exercise, their presence warrants:

• Serum creatinine measurement
• Blood pressure check
• Consideration of phase-contrast microscopy to evaluate for dysmorphic RBCs
• Nephrology consultation if any renal dysfunction indicators present

The calcium oxalate crystals are typically benign but document:

• Dietary history
• History of nephrolithiasis
• Metabolic evaluation if recurrent stone former

Algorithm Summary

1. Week 0: Treat UTI/fungal infection after obtaining cultures
2. Week 12: Repeat urinalysis to confirm persistent hematuria
3. If hematuria persists:
   • Risk stratify using 2025 AUA criteria
   • Order CT urography (or ultrasound if age ≤40 and low-risk)
   • Refer for cystoscopy
   • Check serum creatinine and consider nephrology referral given hyaline casts
4. If hematuria resolves: Annual urinalysis monitoring for 2 years if any risk factors present

The most critical error to avoid is attributing all hematuria to infection and failing to complete urologic evaluation after treatment 1, 2.